Fresenius Medical Care Aktie
WKN: 578580 / ISIN: DE0005785802
30.07.2024 16:30:56
|
EQS-CMS: Fresenius Medical Care AG : Release according to Article 50 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
EQS Post-admission Duties announcement: Fresenius Medical Care AG
/ Third country release according to Article 50 Para. 1, No. 2 of the WpHG [the German Securities Trading Act]
Fresenius Medical Care AG has filed its report on Form 6-K for the 2nd quarter 2024 with the U.S. Securities and Exchange Commission (SEC). The report is available on the website https://www.freseniusmedicalcare.com/en/investors/publications .
30.07.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | Fresenius Medical Care AG |
Else-Kröner-Straße 1 | |
61352 Bad Homburg | |
Germany | |
Internet: | www.freseniusmedicalcare.com |
End of News | EQS News Service |
|
1957337 30.07.2024 CET/CEST

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Fresenius Medical Care (FMC) St.mehr Nachrichten
17.06.25 |
EQS-PVR: Fresenius Medical Care AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group) | |
17.06.25 |
Zurückhaltung in Frankfurt: LUS-DAX beendet die Dienstagssitzung mit Verlusten (finanzen.at) | |
17.06.25 |
Schwache Performance in Frankfurt: DAX präsentiert sich schlussendlich schwächer (finanzen.at) | |
17.06.25 |
Schwacher Handel: LUS-DAX legt am Nachmittag den Rückwärtsgang ein (finanzen.at) | |
17.06.25 |
XETRA-Handel So performt der DAX nachmittags (finanzen.at) | |
17.06.25 |
ROUNDUP: FMC will Profitabilität steigern - Aktienrückkäufe - Kurs unter Druck (dpa-AFX) | |
17.06.25 |
AKTIE IM FOKUS 2: FMC unter Druck - Mittelfristiges Umsatzziel wird vermisst (dpa-AFX) | |
17.06.25 |
ANALYSE-FLASH: Jefferies belässt FMC auf 'Underperform' - Ziel 40 Euro (dpa-AFX) |
Analysen zu Fresenius Medical Care (FMC) St.mehr Analysen
17.06.25 | Fresenius Medical Care Neutral | UBS AG | |
17.06.25 | Fresenius Medical Care Underperform | Jefferies & Company Inc. | |
06.06.25 | Fresenius Medical Care Underweight | JP Morgan Chase & Co. | |
30.05.25 | Fresenius Medical Care Underperform | Jefferies & Company Inc. | |
26.05.25 | Fresenius Medical Care Neutral | UBS AG |
Aktien in diesem Artikel
Fresenius Medical Care (FMC) St. | 46,96 | -4,59% |
|